Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis

C Arum, H Fraser, AA Artenie, S Bivegete… - The Lancet public …, 2021 - thelancet.com
Background People who inject drugs (PWID) are at increased risk for HIV and hepatitis C
virus (HCV) infection and also have high levels of homelessness and unstable housing. We …

Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: a …

J Grebely, L Tran, L Degenhardt… - Clinical Infectious …, 2021 - academic.oup.com
Background People who inject drugs (PWID) experience barriers to accessing testing and
treatment for hepatitis C virus (HCV) infection. Opioid agonist therapy (OAT) may provide an …

[HTML][HTML] Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada

J Broad, K Mason, M Guyton, B Lettner… - International Journal of …, 2020 - Elsevier
Background People who inject drugs have high rates of hepatitis C (HCV) and yet many
remain undiagnosed and untreated. HCV treatment guidelines and elimination strategies …

Elimination of hepatitis C virus infection among people who use drugs: ensuring equitable access to prevention, treatment, and care for all

J Grebely, B Hajarizadeh, JV Lazarus… - International Journal of …, 2019 - Elsevier
There have been major strides towards the World Health Organization goal to eliminate
hepatitis C virus (HCV) infection as a global public health threat. The availability of simple …

Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs

SB Høj, B Jacka, N Minoyan, AA Artenie… - International Journal of …, 2019 - Elsevier
As direct-acting antiviral (DAA) therapy costs fall and eligibility criteria are relaxed, people
who inject drugs (PWID) will increasingly become eligible for HCV treatment. Yet eligibility …

Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: a modeling analysis

JA Cepeda, P Vickerman, J Bruneau, G Zang… - Drug and alcohol …, 2020 - Elsevier
Background Stimulants, such as amphetamines and cocaine, are widely injected among
people who inject drugs (PWID). Systematic reviews indicate stimulant injection is …

Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system

D Gibbs, O Price, J Grebely, S Larney… - Drug and Alcohol …, 2021 - Elsevier
Background Understanding factors associated with engagement across the hepatitis C virus
(HCV) cascade of care (CoC) among people who inject drugs (PWID) is critical for …

[HTML][HTML] HCV treatment initiation in the era of universal direct acting antiviral coverage–Improvements in access and persistent barriers

N Jiang, J Bruneau, I Makarenko, N Minoyan… - International Journal of …, 2023 - Elsevier
Background Barriers to HCV treatment initiation persisted after the introduction of direct-
acting antivirals (DAAs) in Canada among people who inject drugs (PWID); whether DAA …

Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use

AA Artenie, E Fortier, MP Sylvestre, SB Høj… - International Journal of …, 2021 - Elsevier
Background Little is known about how socioeconomic circumstances relate to injection
frequencies among people who inject drugs (PWID) with diverse trajectories of injection. We …

Reaching hard-to-reach people who use drugs: a community-based strategy for the elimination of hepatitis C

N Nagot, M D'ottavi, C Quillet… - Open forum …, 2022 - academic.oup.com
Background Elimination of hepatitis C virus (HCV) among people who use drugs (PWUD)
remains a challenge even in countries in which HCV care is provided free of cost. We …